| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8680351 | Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring | 2017 | 9 Pages |
Abstract
These findings support the use of plasma Aβ42/40 ratios as surrogate biomarkers of cortical Aβ deposition and enrichment tools, reducing the number of subjects submitted to invasive tests and, consequently, recruitment costs in clinical trials targeting cognitively normal individuals.
Keywords
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Noelia Fandos, Virginia Pérez-Grijalba, Pedro Pesini, Salvador Olmos, MatÃas Bossa, Victor L. Villemagne, James Doecke, Christopher Fowler, Colin L. Masters, Manuel Sarasa, AIBL Research Group AIBL Research Group,